blepharospasm

Botulinum toxin type A is used in many neurological diseases such as blepharospasm, cervical dystonia, large muscle spastic disorders, writer's cramp, tremor, hyperhidrosis and pain (12-20).

Among the tardive syndromes, tardive blepharospasm refers to a repetitive, persistent, and severe spasm of the orbicularis oculi muscle as an isolated condition.

Mild blepharedema, moderate blepharospasm, and epiphora OS were present.

In 2006, she was diagnosed with a rare condition called blepharospasm, an involuntary contraction of one of the muscles that controls the eyelids, causing them to close.

Animals with corneal ulcers present clinical signs of epiphora, pawing, blepharospasm, photophobia, and corneal opacity [10].

No confirmed reports have been made of serious toxin spread when Botox has been used at the recommended dose to treat chronic migraine, hyperhidrosis, blepharospasm, or strabismus or when Botox Cosmetic has been used at the recommended dose to treat frown lines, the agency said.

BoNT is the first bacterial toxin licensed by USFDA as 'occulinum' a drug for the treatment of blepharospasm in 1989.

Botox was approved by the FDA in 1989 for treatment of blepharospasm and strabismus.

Local injections of botulinum A exotoxin (BTX) have been used successfully to treat strabismus, blepharospasm, and other hyperkinetic movement disorders [1].

It is important to distinguish this process from other types of facial spasm, such as psychogenic facial spasm, facial tic, facial myokymia, blepharospasm, and tardive dyskinesia.

Botox also is approved for cervical dystonia, as well as for strabismus, blepharospasm, and primary axillary hyperhidrosis.

Botox (botulinum toxin type A) also is approved for cervical dystonia, as well as for strabismus, blepharospasm, and primary axillary hyperhidrosis.

A YOU give a typical description, Anne, for blepharospasm - any abnormal twitch or tic of the eyelid.

8) Current FDA approved uses of Botox therapy have been expanded to include treatment of glabellar lines, blepharospasm, strabismus, and cervical dystonia.

77-81) Results of these studies indicate that the majority of patients with blepharospasm, cervical dystonia, Meige syndrome, and hemifacial spasm continued botulinum toxin type A treatment--some up to 11 years or until death of unrelated causes (Table 3).